Gershoni Jonathan M, Roitburd-Berman Anna, Siman-Tov Dror D, Tarnovitski Freund Natalia, Weiss Yael
Department of Cell Research and Immunology, Tel Aviv University, Tel-Aviv, Israel.
BioDrugs. 2007;21(3):145-56. doi: 10.2165/00063030-200721030-00002.
Antibodies are an effective line of defense in preventing infectious diseases. Highly potent neutralizing antibodies can intercept a virus before it attaches to its target cell and, thus, inactivate it. This ability is based on the antibodies' specific recognition of epitopes, the sites of the antigen to which antibodies bind. Thus, understanding the antibody/epitope interaction provides a basis for the rational design of preventive vaccines. It is assumed that immunization with the precise epitope, corresponding to an effective neutralizing antibody, would elicit the generation of similarly potent antibodies in the vaccinee. Such a vaccine would be a 'B-cell epitope-based vaccine', the implementation of which requires the ability to backtrack from a desired antibody to its corresponding epitope. In this article we discuss a range of methods that enable epitope discovery based on a specific antibody. Such a reversed immunological approach is the first step in the rational design of an epitope-based vaccine. Undoubtedly, the gold standard for epitope definition is x-ray analyses of crystals of antigen:antibody complexes. This method provides atomic resolution of the epitope; however, it is not readily applicable to many antigens and antibodies, and requires a very high degree of sophistication and expertise. Most other methods rely on the ability to monitor the binding of the antibody to antigen fragments or mutated variations. In mutagenesis of the antigen, loss of binding due to point modification of an amino acid residue is often considered an indication of an epitope component. In addition, computational combinatorial methods for epitope mapping are also useful. These methods rely on the ability of the antibody of interest to affinity isolate specific short peptides from combinatorial phage display peptide libraries. The peptides are then regarded as leads for the definition of the epitope corresponding to the antibody used to screen the peptide library. For epitope mapping, computational algorithms have been developed, such as Mapitope, which has recently been found to be effective in mapping conformational discontinuous epitopes. The pros and cons of various approaches towards epitope mapping are also discussed.
抗体是预防传染病的有效防线。高效的中和抗体可在病毒附着到靶细胞之前将其拦截,从而使其失活。这种能力基于抗体对表位的特异性识别,表位是抗体结合的抗原位点。因此,了解抗体/表位相互作用为合理设计预防性疫苗提供了基础。据推测,用与有效中和抗体对应的精确表位进行免疫接种,将在接种疫苗者体内引发产生同样强效的抗体。这样的疫苗将是一种“基于B细胞表位的疫苗”,其实施需要具备从所需抗体追溯到其相应表位的能力。在本文中,我们讨论了一系列基于特定抗体进行表位发现的方法。这种反向免疫学方法是合理设计基于表位的疫苗的第一步。毫无疑问,表位定义的金标准是对抗原:抗体复合物晶体进行X射线分析。这种方法可提供表位的原子分辨率;然而,它并不适用于许多抗原和抗体,并且需要非常高的技术水平和专业知识。大多数其他方法依赖于监测抗体与抗原片段或突变变体结合的能力。在对抗原进行诱变时,由于氨基酸残基的点修饰导致结合丧失通常被视为表位成分的一个指标。此外,用于表位作图的计算组合方法也很有用。这些方法依赖于感兴趣的抗体从组合噬菌体展示肽库中亲和分离特定短肽的能力。然后将这些肽视为用于定义与用于筛选肽库的抗体相对应的表位的线索。对于表位作图,已经开发了计算算法,如Mapitope,最近发现它在绘制构象不连续表位方面很有效。还讨论了各种表位作图方法的优缺点。